In patient tumor, CD69-expressing cells exhibited a rather low glucose dependency, a parameter associated with longer PFS, hence better prognosis, and a high FAO/AAO capacity, whereas it was the opposite for PD1-expressing cells. The gene discussed is CD69; the disease is neoplasm.